Literature DB >> 31335523

In Vivo and Ex Vivo Comprehensive Evaluation of Corneal Reinnervation in Eyes Neurotized With Contralateral Supratrochlear and Supraorbital Nerves.

Giuseppe Giannaccare1,2, Federico Bolognesi3, Federico Biglioli4, Claudio Marchetti3, Silvia Mariani1, Jayne S Weiss5, Fabiana Allevi4, Federica E Cazzola1, Diego Ponzin6, Alessandro Lozza7, Cristina Bovone8,9,10, Vincenzo Scorcia2, Massimo Busin8,9,10, Emilio C Campos1.   

Abstract

PURPOSE: To use an automated morphometric analysis system of in vivo confocal microscopy (IVCM) images for evaluating reinnervation occurring at the subbasal nerve plexus (SNP) after direct corneal neurotization (DCN) and to further report neurophysiological and histopathological findings.
METHODS: Prospective interventional case series including 3 eyes with neurotrophic keratitis that underwent DCN. Deep anterior lamellar keratoplasty was performed 18 months after DCN in patient 1. The following evaluations were performed before and at 3, 6, and 12 months after DCN: clinical evolution of keratitis; corneal sensitivity; IVCM images of the SNP analyzed with "ACCMetrics;" neurophysiological study of corneal reflex. Protein gene product 9.5 immunofluorescence staining assay and transmission electron microscopy were conducted on the neurotized button excised during deep anterior lamellar keratoplasty.
RESULTS: Complete healing was obtained in all patients by 3 months postoperatively. Corneal sensitivity was absent preoperatively in all eyes and improved after surgery, reaching an average value of 30 mm 1 year postoperatively. The corneal SNP was not visible at IVCM in any of the cases preoperatively and became visible by 3 months postoperatively, showing IVCM metrics comparable to normal contralateral eyes at 1 year. In all cases, neurophysiological evaluation showed a partial recovery of the electrical activity of the cornea. In patient 1, protein gene product (PGP) 9.5 staining of neurotized cornea showed nerve fascicles at the SNP, whereas transmission electron microscopy showed amyelinic nerve axons and nerve endings.
CONCLUSIONS: The corneal SNP exhibited IVCM metrics comparable to the normal contralateral eye 1 year after DCN. Ex vivo histopathological assessment of neurotized corneas confirmed the presence of nerves with normal ultrastructure.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31335523     DOI: 10.1097/ICO.0000000000002083

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  Corneal neurotization for neurotrophic keratopathy: Review of surgical techniques and outcomes.

Authors:  Catherine Y Liu; Andrea C Arteaga; Sammie E Fung; M Soledad Cortina; Ilya M Leyngold; Vinay K Aakalu
Journal:  Ocul Surf       Date:  2021-02-26       Impact factor: 5.033

Review 2.  Regenerative therapy for the Cornea.

Authors:  Ajay Kumar; Hongmin Yun; Martha L Funderburgh; Yiqin Du
Journal:  Prog Retin Eye Res       Date:  2021-09-14       Impact factor: 21.198

Review 3.  Alternative therapies for dry eye disease.

Authors:  Rhiya Mittal; Sneh Patel; Anat Galor
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

4.  Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: Case report and literature review.

Authors:  Giuseppe Giannaccare; Andrea Lucisano; Marco Pellegrini; Gianfranco Scuteri; Alessandra Mancini; Cristina Malaventura; Massimo Busin; Vincenzo Scorcia
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-18

Review 5.  Neurotization of the human cornea - A comprehensive review and an interim report.

Authors:  Anubha Rathi; Nandini Bothra; Smruti R Priyadarshini; Divya S R Achanta; Merle Fernandes; Somasheila I Murthy; Anasua G Kapoor; Tarjani V Dave; Suryasnata Rath; Rajesh Yellinedi; Rambabu Nuvvula; Gautam Dendukuri; Milind N Naik; Muralidhar Ramappa
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

Review 6.  Ocular manifestations of herpes simplex virus.

Authors:  Gabriel S Valerio; Charles C Lin
Journal:  Curr Opin Ophthalmol       Date:  2019-11       Impact factor: 3.761

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.